Jefferies Provides Color On Integra LifeSciences Holdings

Jefferies published a note on Integra LifeSciences Holdings

today after the company's long-time CEO Stuart Essig stepped down. COO Peter Arduini will take his place. Jefferies has a Buy rating and $43 price target for Integra LifeSciences. In the report, Jefferies stated, "Stuart Essig has been the chief architect of the acquisition-driven strategy that has served Integra well over the past 14 years. His departure likely represents a new chapter for the company, one more reliant on value creation through 'operating well' rather than through acquisition." Shares of Integra LifeSciences Holdings closed at $31.19 today, down 0.22% from Tuesday's close.